SlideShare a Scribd company logo
1 of 46
The UC San Diego AntiViral Research Center sponsors weekly
presentations by infectious disease clinicians, physicians and
researchers. The goal of these presentations is to provide the most
current research, clinical practices and trends in HIV, HBV, HCV, TB
and other infectious diseases of global significance.
The slides from the AIDS Clinical Rounds presentation that you are
about to view are intended for the educational purposes of our
audience. They may not be used for other purposes without the
presenter’s express permission.
AIDS CLINICAL ROUNDS
Network Informed Prevention
Study?
Davey Smith, MD
Associate Professor of Medicine
UCSD
Who knows who these guys?
John Snow’s Map
Cholera Outbreak: space and time
http://en.wikipedia.org/wiki/John_Snow_%28physician%29
Snow Veterinary Research 2011 42:56 doi:10.1186/1297-9716-42-56
How to define a network
 Contact versus Transmission
◦ Behavior
◦ Social
◦ Venue
 Molecular (genetic relatedness)
◦ Origins
◦ Timing
◦ Transmission linkages
◦ Transmission networks
Retroviruses. Cold Spring Harbor Laboratory Press; c1997. Van Heuverswyn F. et al
Nature. 2006 Nov 9;444(7116):164. Kober et al. Science 2000.
Why Father’s Day is Important
Do Genetic Backgrounds Matter?
(Or how to blame everything on your parents)
Smithsonian Natural History Museum 2011 www.hiv.lanl.gov/content/sequence/HIV/RE
VIEWS/nomenclature/Nomen.html
Kosakovsky Pond and Smith Clin Infect Dis. 2009 May 1;48(9):1306-9.
Viral Background
Host Background (e.g. HLA)
CTL
How can background genetics influence HIV disease?
Defining Transmission Network and
Clusters in San Diego
 Even in this geographically localized and aggressively sampled
cohort, genetic distances <1.5% were very rare (0.25 %).
Pairwise Nucleotide Distance
Count
0.00 0.05 0.10 0.15
0100030005000
Distances <1.5%
0.000 0.005 0.010 0.015
020406080
Potential transmission
Network
N=921 unique seqs
Non-subtype B
Switching Gears
Networks are everywhere
How many can you name is10 seconds?
Network structure
http://cleverdeveloper.com/blog/?p=111
SO CAN MOLECULAR
EPIDEMIOLOGYTELL US
ANYTHING ABOUT
NETWORKS?
HIV is transmitted along a complex contact network
Concept Contact Network Transmission network
Node Individual HIV+ individual
Edge A contact that could lead to HIV transmission,
e.g. sexual, shared needle
Transmission event
Degree = edges
connected to a node
Number of contacts associated with a node Number of transmissions
associated with a node
HIV+ HIV-
Contact w/o tranmission
Transmission
Degree = 7
Degree = 1
Degree = 3
Transmission network is a
subset of the contact network
HIV Molecular Epidemiology Has
Been Used Before
 Montreal and London: Primary infection drives local
epidemics. (Brenner JID 2007, Fraser PLoS Med 2008, Leigh Brown JID 2011)
 San Diego: Partner tracing identifies hubs. (Smith AIDS
2009)
 Tijuana/San Diego: border offers some barrier (Mehta
ARHR 2010)
 Europe: some countries serve as hubs (Retrovirology 2009)
 United States: Clustering associated with
◦ Not using ARVs
◦ CD4 >350 cells/ml
◦ Viral load 10,000-100,000 copies/ml
◦ Women cluster with other women
◦ African Americans clustered with other African Americans
(Aldous CID 2012)
Mol Epi-Network techniques are powerful
 Can readily infer patterns of world-wide HIV-1
transmission
 Found 4342 clusters using ~85,000 sequences from 141
countries.
 A large IDU and MSM cluster spanned 18 countries
(primarily from the former USSR).
Wertheim JID 2013
Defining Transmission Network and
Clusters in San Diego
 Even in this geographically localized and aggressively sampled
cohort, genetic distances <1.5% were very rare (0.25 %).
Pairwise Nucleotide Distance
Count
0.00 0.05 0.10 0.15
0100030005000
Distances <1.5%
0.000 0.005 0.010 0.015
020406080
Potential transmission
Network
N=921 unique seqs
Non-subtype B
What kind of HIV network is
San Diego?
A random intervention would not work in a scale
free network, but a targeted intervention would!
Scale-free network
Same size but one has
Hubs
Random network
San Diego Network is Scale Free
and Deeply Sampled
Count
50100150
2000 2002 2004 2006 2008 2010
2050100200500
Year
Nodes
Edges
So, can we use molecular epi and
networks to do anything meaningful?
 Hypothesis:We can reduce R0<1 in the
San Diego HIV epidemic by identifying
and intervening on the “hubs” of the
network.
Properties of SDPIC network
 54% of individuals connected to someone
else
 A small proportion of individuals have many
connections (high degree)
 HIV transmission networks largely follow the
model of preferential attachment – high
degree nodes attract more new connections.
 Perhaps the network degree of the individual
can be informative for intervention?
It pays to target highly connected
nodes
Degree = 7
Degree = 1
Targeting a low degree
node has a local effect
Targeting a high degree
node has a global effect
Transmission Network Score
 DefineTNS as extent of the observed out-degree of the node and probability
estimated from network degree distribution for the year of sampling.
 A highly connected node has a high likelihood to have future connections-TNS
Cluster
Transmission Network Score
 For each participant, we determined the degree (i.e.
‘connectivity’) of their node within the network on the date
that corresponded to the first HIV pol sequence.
 This was then used to predict how many new edges (i.e.
contacts) the participant would acquire within the first year
following their baseline sequence.
Early versus delayed treatment
LET USVISUALIZETHE
PROBLEM
Brought to you by Nadir Weibel
and Sanjay Mehta
Applications
 Help us to understand the origins and
dispersal of viral epidemics
 Reconstructing the history of
epidemics
Understanding the detailed epidemiology of an
epidemic in real time may help us design, prioritize
and direct prevention efforts
Obtaining a granular understanding of how the HIV
epidemic occurred in a particular region will help us with
future predictions on the how the epidemic will progress
Example
We find that HIV transmissions are occurring at a slow steady rate in
IVDU, but occurring in bursts of related infections in MSM
How?
Suggests that we use this information to focus
resources on contact tracing of acutely infected
MSM
Obtaining a real-time picture of the HIV epidemic in a
region complete with socio-demographic correlates of
risk will help us choose and target our interventions
Example
 Several new HIV infections are identified among heterosexual
migrant farm-workers that are not IVDU
 Infections are linked together, and to several infections
identified in another migrant farm-worker camp
How?
Suggests that we target our interventions
toward sex workers servicing these camps
 Clever Information Visualization helps in
making hidden connections apparent
New Methods?
Finding the cause of a cholera
outbreak
John Snow’s map of London of
1854 allowed to trace back an
unexplainable outbreak to a
malfunctioning water pump on
Broad Street
… just by superimposing cholera
cases (in red) on the street map.
Visualizing HIV Tracking: Challenges (1)
 (Too?) many variables
◦ Demographic information (e.g. age, gender, race, ethnicity,
marital status, sexual orientation, education level, birth
country and city)
◦ Clinical data (e.g. HIV stage at diagnosis, current CD4 levels,
HAART use)
◦ HIV sequence and phylogenetic clustering
◦ Sexually transmitted infections and sexual risk (e.g.
transaction sex, commercial sex, number of partners)
◦ Illicit drug use (e.g. needle sharing, use of heroin, meth,
alcohol)
◦ Risk venues (e.g. bathhouses, adult bookstores, bars,
internet sites used to meet partners for sex or drug use)
◦ Geography (e.g. residence, border crossing).
Visualizing HIV Tracking: Challenges (2)
 Continuous data over time
◦ How do we visualize trends?
◦ How can we identify significant snapshots?
 Unknown relationships between variables
◦ How do variable influence each other?
◦ Different views on data highlight different relationships
 Different kind of networks
◦ Phylogenetic
◦ Geographic
◦ Social
Approach
 Stanford’s Data-Driven Documents
(D3)
D3: Data-Driven Documents
Michael Bostock, Vadim Ogievetsky, Jeffrey Heer
IEEE Trans. Visualization & Comp. Graphics (Proc. InfoVis),
2011
http://d3js.org/
http://vis.stanford.edu/papers/d3
D3 Example / Inspiration
Preliminary work (1)
 HIV Datasets
◦ >1000 data entries collected
◦ 3 different sites:
 Primary Infection Cohort
 UCSD Owen Clinic
 San Diego County Epidemiology Department
 Phylogenetic cluster analysis
◦ Distance between single sequences
◦ 111 clusters found
Preliminary Work (2)
 Visualization
◦ Clusters grouped in circles
◦ Descriptive statistics for the cluster
 Number of subjects per cluster (size of the circle)
 average age (color of the circle)
 male/female percentage
 Ethnicity
 Sexual Orientation
Demo
Next Steps
 Multi-layered descriptions of
phylogenetic clusters
 Network connectivity within
the cluster and across clusters
 Time-based dynamic update of
clusters
 Identification of specific
important changes
In a (not too) far future?
 Dynamic Real-time
Geographic visualizations
 Automatic detection of
anomalies
◦ Machine learning algorithms
 Ultra-ScaleVisualizations
◦ Calit2 Wall Displays
(VROOM)
Public Health Approach
• Prevention measures cannot be a one-size fits all.
• Use network analytical methods to characterize
HIV transmission dynamics within a population
• Use network and phylogenetic methods to identify
cores, bridges and hubs
• Focus outreach and prevention programs on
identified cores, bridges and hubs
• Since network dynamics can change (venues,
susceptible populations, STIs, drug use, etc.)
network surveillance should also be dynamic.
• Epidemiologic surveillance
• HIV genetic surveillance (genotypes)
41
Legal:Take the ‘C’ out of CSI
 The identification of individuals who have
transmitted HIV can have significant legal
implications.
 Therefore for these data to be used for public
health purposes there must be:
◦ Decriminalization of unintended HIV transmission during
consensual exposure.
◦ Legal recognition that phylogenetic linkage using pol
sequences does not prove beyond a reasonable doubt
that transmission between partners occurred, such as
with a third party intermediary
◦ The legal precedent for admitting phylogenetic evidence
has set the bar extremely high [Scaduto PNAS, 2010], and
requires very complex analyses of multiple source and
recipient sequence isolates.
42
Analyze HIV pol
sequences in real
time in the
background of all
sequences
Generate
TNS
TNS
high
Generate Risk Profile and
Intervention Plan
DatAvailable for Risk Profile
• Demographics
• Risk behavior (MSM, IDU)
• Venues (bars, bathhouses, shooting galleries, internet sites)
• Estimated duration of infection (acute, early, chronic)
• Clinical (CD4 and viral load)
• No personally identifying information
Ring Intervention
Target identified venues
HIV Testing, Counseling, STI testing,
Needle Exchange, etc.
Intervention Team
• Nurse
• Social worker
• Test Counselor
Intervention success can be
measured by observing phylogenetic
lineages dying out (Wertheim et al.
2011)
TNS low=
follow
Take Home Message
Coverage- Acknowledgements
Sanjay Mehta
Nadir Weibel
Sergei Kosakovsky Pond
Susan Little
Kimberly Bouwer
Richard Garfein
Igor Grant
Tom Patterson
Doug Richman
Stephanie Strathdee
Jason Young
Joel Wertheim

More Related Content

Viewers also liked

Midsummer Presentation Slides
Midsummer Presentation SlidesMidsummer Presentation Slides
Midsummer Presentation SlidesJennifer Rust
 
About Webfactories USA and Third Generation Websites
About Webfactories USA and Third Generation WebsitesAbout Webfactories USA and Third Generation Websites
About Webfactories USA and Third Generation WebsitesWebfactories USA
 
Tuberculosis Screening in Healthcare Workers at Maputo Central Hospital
Tuberculosis Screening in Healthcare Workers at Maputo Central HospitalTuberculosis Screening in Healthcare Workers at Maputo Central Hospital
Tuberculosis Screening in Healthcare Workers at Maputo Central HospitalUC San Diego AntiViral Research Center
 
How Stories Can Boost Your Marketing Success - Jan 28 Panel NorCal BMA
How Stories Can Boost Your Marketing Success - Jan 28 Panel NorCal BMAHow Stories Can Boost Your Marketing Success - Jan 28 Panel NorCal BMA
How Stories Can Boost Your Marketing Success - Jan 28 Panel NorCal BMANorCal Business Marketing Association
 
Genetic Differences in Vulnerability to Methamphetamine-related Brain Dysfunc...
Genetic Differences in Vulnerability to Methamphetamine-related Brain Dysfunc...Genetic Differences in Vulnerability to Methamphetamine-related Brain Dysfunc...
Genetic Differences in Vulnerability to Methamphetamine-related Brain Dysfunc...UC San Diego AntiViral Research Center
 
Update from the 15th International Workshop on Co-Morbidities and Adverse Dru...
Update from the 15th International Workshop on Co-Morbidities and Adverse Dru...Update from the 15th International Workshop on Co-Morbidities and Adverse Dru...
Update from the 15th International Workshop on Co-Morbidities and Adverse Dru...UC San Diego AntiViral Research Center
 
HPV and Anal Dysplasia: Current Considerations for Screening and Management
HPV and Anal Dysplasia: Current Considerations for Screening and ManagementHPV and Anal Dysplasia: Current Considerations for Screening and Management
HPV and Anal Dysplasia: Current Considerations for Screening and ManagementUC San Diego AntiViral Research Center
 
Toxoplasmosis, Malaria, and HIV: Impact of Latent Co-infection on HIV Disease
Toxoplasmosis, Malaria, and HIV: Impact of Latent Co-infection on HIV DiseaseToxoplasmosis, Malaria, and HIV: Impact of Latent Co-infection on HIV Disease
Toxoplasmosis, Malaria, and HIV: Impact of Latent Co-infection on HIV DiseaseUC San Diego AntiViral Research Center
 
Tokoh Islam Nusantara : Tok Kenali
Tokoh Islam Nusantara : Tok KenaliTokoh Islam Nusantara : Tok Kenali
Tokoh Islam Nusantara : Tok Kenalipakjhu
 
The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center UC San Diego AntiViral Research Center
 

Viewers also liked (17)

Midsummer Presentation Slides
Midsummer Presentation SlidesMidsummer Presentation Slides
Midsummer Presentation Slides
 
NorCalBMA: Competing against free
NorCalBMA: Competing against freeNorCalBMA: Competing against free
NorCalBMA: Competing against free
 
Privacy vs. Public Health
Privacy vs. Public HealthPrivacy vs. Public Health
Privacy vs. Public Health
 
About Webfactories USA and Third Generation Websites
About Webfactories USA and Third Generation WebsitesAbout Webfactories USA and Third Generation Websites
About Webfactories USA and Third Generation Websites
 
Tuberculosis Screening in Healthcare Workers at Maputo Central Hospital
Tuberculosis Screening in Healthcare Workers at Maputo Central HospitalTuberculosis Screening in Healthcare Workers at Maputo Central Hospital
Tuberculosis Screening in Healthcare Workers at Maputo Central Hospital
 
How Stories Can Boost Your Marketing Success - Jan 28 Panel NorCal BMA
How Stories Can Boost Your Marketing Success - Jan 28 Panel NorCal BMAHow Stories Can Boost Your Marketing Success - Jan 28 Panel NorCal BMA
How Stories Can Boost Your Marketing Success - Jan 28 Panel NorCal BMA
 
Medicinal Cannabis
Medicinal CannabisMedicinal Cannabis
Medicinal Cannabis
 
Genetic Differences in Vulnerability to Methamphetamine-related Brain Dysfunc...
Genetic Differences in Vulnerability to Methamphetamine-related Brain Dysfunc...Genetic Differences in Vulnerability to Methamphetamine-related Brain Dysfunc...
Genetic Differences in Vulnerability to Methamphetamine-related Brain Dysfunc...
 
Update from the 15th International Workshop on Co-Morbidities and Adverse Dru...
Update from the 15th International Workshop on Co-Morbidities and Adverse Dru...Update from the 15th International Workshop on Co-Morbidities and Adverse Dru...
Update from the 15th International Workshop on Co-Morbidities and Adverse Dru...
 
The Great Imitator in 2013 – Syphilis and HIV Infection
The Great Imitator in 2013 – Syphilis and HIV InfectionThe Great Imitator in 2013 – Syphilis and HIV Infection
The Great Imitator in 2013 – Syphilis and HIV Infection
 
HPV and Anal Dysplasia: Current Considerations for Screening and Management
HPV and Anal Dysplasia: Current Considerations for Screening and ManagementHPV and Anal Dysplasia: Current Considerations for Screening and Management
HPV and Anal Dysplasia: Current Considerations for Screening and Management
 
Immune Activation in Treated HIV Infection
Immune Activation in Treated  HIV InfectionImmune Activation in Treated  HIV Infection
Immune Activation in Treated HIV Infection
 
Toxoplasmosis, Malaria, and HIV: Impact of Latent Co-infection on HIV Disease
Toxoplasmosis, Malaria, and HIV: Impact of Latent Co-infection on HIV DiseaseToxoplasmosis, Malaria, and HIV: Impact of Latent Co-infection on HIV Disease
Toxoplasmosis, Malaria, and HIV: Impact of Latent Co-infection on HIV Disease
 
The Latest on HIV Cure Strategies
The Latest on HIV Cure StrategiesThe Latest on HIV Cure Strategies
The Latest on HIV Cure Strategies
 
Tokoh Islam Nusantara : Tok Kenali
Tokoh Islam Nusantara : Tok KenaliTokoh Islam Nusantara : Tok Kenali
Tokoh Islam Nusantara : Tok Kenali
 
The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center The HCV Treatment Revolution: A View from the Community Health Center
The HCV Treatment Revolution: A View from the Community Health Center
 
End of Life Care: Discussions and Medical Decision Making
End of Life Care: Discussions and Medical Decision MakingEnd of Life Care: Discussions and Medical Decision Making
End of Life Care: Discussions and Medical Decision Making
 

Similar to How Should We Target Prevention Interventions?

Non compartmental s-i-s modeling of hiv prevalence in 7 countries of the world
Non compartmental s-i-s modeling of hiv prevalence in 7 countries of the worldNon compartmental s-i-s modeling of hiv prevalence in 7 countries of the world
Non compartmental s-i-s modeling of hiv prevalence in 7 countries of the worldAlexander Decker
 
HIV Epidemiology in the Prairies
HIV Epidemiology in the PrairiesHIV Epidemiology in the Prairies
HIV Epidemiology in the Prairiesgriehl
 
RDS_PWID_CROATIA_poster_ECCMID_2016
RDS_PWID_CROATIA_poster_ECCMID_2016RDS_PWID_CROATIA_poster_ECCMID_2016
RDS_PWID_CROATIA_poster_ECCMID_2016Senad Handanagić
 
Dengue Transmission and Risk Factors in Dhaka, Bangladesh
Dengue Transmission and Risk Factors in Dhaka, Bangladesh Dengue Transmission and Risk Factors in Dhaka, Bangladesh
Dengue Transmission and Risk Factors in Dhaka, Bangladesh Global Risk Forum GRFDavos
 
People With HIV Whose Viral Loads Are Undetectable Present.pdf
People With HIV Whose Viral Loads Are Undetectable Present.pdfPeople With HIV Whose Viral Loads Are Undetectable Present.pdf
People With HIV Whose Viral Loads Are Undetectable Present.pdfThe Lifesciences Magazine
 
HIV in Emergencies: From research to strategies, policies and results
HIV in Emergencies: From research to strategies, policies and resultsHIV in Emergencies: From research to strategies, policies and results
HIV in Emergencies: From research to strategies, policies and resultsHopkinsCFAR
 
AIDSVu: Mapping HIV Surveillance Data and Promoting HIV Testing
AIDSVu: Mapping HIV Surveillance Data and Promoting HIV TestingAIDSVu: Mapping HIV Surveillance Data and Promoting HIV Testing
AIDSVu: Mapping HIV Surveillance Data and Promoting HIV TestingCDC NPIN
 
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...UC San Diego AntiViral Research Center
 
e632 www.thelancet.comhiv Vol 6 September 2019Viewpoi
e632 www.thelancet.comhiv   Vol 6   September 2019Viewpoie632 www.thelancet.comhiv   Vol 6   September 2019Viewpoi
e632 www.thelancet.comhiv Vol 6 September 2019ViewpoiAlyciaGold776
 
Barry Adam, "The biomedical and the social in HIV prevention"
Barry Adam, "The biomedical and the social in HIV prevention"Barry Adam, "The biomedical and the social in HIV prevention"
Barry Adam, "The biomedical and the social in HIV prevention"CBRC
 
Mathematical modeling
Mathematical modelingMathematical modeling
Mathematical modelingmiguelhowella
 
Network medicine
Network medicineNetwork medicine
Network medicinestepano7
 

Similar to How Should We Target Prevention Interventions? (20)

Strategies for HIV Epidemic Control
Strategies for HIV Epidemic ControlStrategies for HIV Epidemic Control
Strategies for HIV Epidemic Control
 
Pirc net poster
Pirc net posterPirc net poster
Pirc net poster
 
Non compartmental s-i-s modeling of hiv prevalence in 7 countries of the world
Non compartmental s-i-s modeling of hiv prevalence in 7 countries of the worldNon compartmental s-i-s modeling of hiv prevalence in 7 countries of the world
Non compartmental s-i-s modeling of hiv prevalence in 7 countries of the world
 
HIV Epidemiology in the Prairies
HIV Epidemiology in the PrairiesHIV Epidemiology in the Prairies
HIV Epidemiology in the Prairies
 
Barriers of HIV Prevention through Treatment
Barriers of HIV Prevention through TreatmentBarriers of HIV Prevention through Treatment
Barriers of HIV Prevention through Treatment
 
Mathematical Models to investigate HIV trends in Australia
Mathematical Models to investigate HIV trends in AustraliaMathematical Models to investigate HIV trends in Australia
Mathematical Models to investigate HIV trends in Australia
 
RDS_PWID_CROATIA_poster_ECCMID_2016
RDS_PWID_CROATIA_poster_ECCMID_2016RDS_PWID_CROATIA_poster_ECCMID_2016
RDS_PWID_CROATIA_poster_ECCMID_2016
 
Dengue Transmission and Risk Factors in Dhaka, Bangladesh
Dengue Transmission and Risk Factors in Dhaka, Bangladesh Dengue Transmission and Risk Factors in Dhaka, Bangladesh
Dengue Transmission and Risk Factors in Dhaka, Bangladesh
 
People With HIV Whose Viral Loads Are Undetectable Present.pdf
People With HIV Whose Viral Loads Are Undetectable Present.pdfPeople With HIV Whose Viral Loads Are Undetectable Present.pdf
People With HIV Whose Viral Loads Are Undetectable Present.pdf
 
HIV in Emergencies: From research to strategies, policies and results
HIV in Emergencies: From research to strategies, policies and resultsHIV in Emergencies: From research to strategies, policies and results
HIV in Emergencies: From research to strategies, policies and results
 
HATS_Medwiser_A
HATS_Medwiser_AHATS_Medwiser_A
HATS_Medwiser_A
 
Hiv Essay
Hiv EssayHiv Essay
Hiv Essay
 
Importance and implication of starting HIV treatment early
Importance and implication of starting HIV treatment earlyImportance and implication of starting HIV treatment early
Importance and implication of starting HIV treatment early
 
AIDSVu: Mapping HIV Surveillance Data and Promoting HIV Testing
AIDSVu: Mapping HIV Surveillance Data and Promoting HIV TestingAIDSVu: Mapping HIV Surveillance Data and Promoting HIV Testing
AIDSVu: Mapping HIV Surveillance Data and Promoting HIV Testing
 
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
04.03.20 | COVID-19 and HIV: What We Know and Efforts to Answer What We Don’t...
 
e632 www.thelancet.comhiv Vol 6 September 2019Viewpoi
e632 www.thelancet.comhiv   Vol 6   September 2019Viewpoie632 www.thelancet.comhiv   Vol 6   September 2019Viewpoi
e632 www.thelancet.comhiv Vol 6 September 2019Viewpoi
 
Barry Adam, "The biomedical and the social in HIV prevention"
Barry Adam, "The biomedical and the social in HIV prevention"Barry Adam, "The biomedical and the social in HIV prevention"
Barry Adam, "The biomedical and the social in HIV prevention"
 
Mathematical modeling
Mathematical modelingMathematical modeling
Mathematical modeling
 
Poster
PosterPoster
Poster
 
Network medicine
Network medicineNetwork medicine
Network medicine
 

More from UC San Diego AntiViral Research Center

06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIVUC San Diego AntiViral Research Center
 
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...UC San Diego AntiViral Research Center
 
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIVUC San Diego AntiViral Research Center
 
03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...
03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...
03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...UC San Diego AntiViral Research Center
 
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited SettingsUC San Diego AntiViral Research Center
 
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and BeyondUC San Diego AntiViral Research Center
 
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)UC San Diego AntiViral Research Center
 
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)UC San Diego AntiViral Research Center
 
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)UC San Diego AntiViral Research Center
 
12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...
12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...
12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...UC San Diego AntiViral Research Center
 
08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...
08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...
08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...UC San Diego AntiViral Research Center
 

More from UC San Diego AntiViral Research Center (20)

10.20.23 | Frailty in People Aging with HIV
10.20.23 | Frailty in People Aging with HIV10.20.23 | Frailty in People Aging with HIV
10.20.23 | Frailty in People Aging with HIV
 
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
06.11.21 | Practical Aspects of Dealing with Weight Gain in People with HIV
 
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
05.07.21 | Not the Same Old Blues: Trails of the Efforts to Improve PrEP Upta...
 
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
04.16.21 | Entering a New Era of HIV Care: Long-Acting Injectables for HIV
 
04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV
04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV
04.09.21 | Making Sense of the COVID-19 Data in Persons with HIV
 
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 202103.19.21 | Updates in HIV Prevention from Virtual CROI 2021
03.19.21 | Updates in HIV Prevention from Virtual CROI 2021
 
03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...
03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...
03.05.21 | Creating an Emergency Response System for Emerging Infectious Dise...
 
02.05.21 | COVID-19 and Pregnancy
02.05.21 | COVID-19 and Pregnancy02.05.21 | COVID-19 and Pregnancy
02.05.21 | COVID-19 and Pregnancy
 
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
 
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
01.22.21 | Video DOT for Monitoring Treatment Adherence for TB, LTBI and Beyond
 
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
 
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
 
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
Military International HIV Training Program (MIHTP) ECHO Rounds (April 27, 2021)
 
12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...
12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...
12.04.20 | COVID-19 Disparities in Black & Latino Communities: Implications f...
 
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
11.13.20 | The Impact of COVID-19 on the Opioid Epidemic
 
10.23.20 | Rise Above COVID (Treatments for COVID-19)
10.23.20 | Rise Above COVID (Treatments for COVID-19)10.23.20 | Rise Above COVID (Treatments for COVID-19)
10.23.20 | Rise Above COVID (Treatments for COVID-19)
 
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
 
09.18.20 | Sustaining the HIV Workforce through Med Ed Innovations
09.18.20 | Sustaining the HIV Workforce through Med Ed Innovations09.18.20 | Sustaining the HIV Workforce through Med Ed Innovations
09.18.20 | Sustaining the HIV Workforce through Med Ed Innovations
 
09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals09.11.20 | Review of New Antiretrovirals
09.11.20 | Review of New Antiretrovirals
 
08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...
08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...
08.28.20 | Update on the Epidemiology of HCV Infection and National Screening...
 

Recently uploaded

Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxDr. Dheeraj Kumar
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...sdateam0
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxSasikiranMarri
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Mohamed Rizk Khodair
 
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxChronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxSasikiranMarri
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxAbhishek943418
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfDivya Kanojiya
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxtadehabte
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...Divya Kanojiya
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 

Recently uploaded (20)

Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
Measurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptxMeasurement of Radiation and Dosimetric Procedure.pptx
Measurement of Radiation and Dosimetric Procedure.pptx
 
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...Big Data Analysis Suggests COVID  Vaccination Increases Excess Mortality Of  ...
Big Data Analysis Suggests COVID Vaccination Increases Excess Mortality Of ...
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Informed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptxInformed Consent Empowering Healthcare Decision-Making.pptx
Informed Consent Empowering Healthcare Decision-Making.pptx
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)Primary headache and facial pain. (2024)
Primary headache and facial pain. (2024)
 
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptxChronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
Chronic-Fatigue-Syndrome-CFS-Understanding-a-Complex-Disorder.pptx
 
SHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptxSHOCK (Medical SURGICAL BASED EDITION)).pptx
SHOCK (Medical SURGICAL BASED EDITION)).pptx
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
Phytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdfPhytochemical Investigation of Drugs PDF.pdf
Phytochemical Investigation of Drugs PDF.pdf
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Screening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptxScreening for colorectal cancer AAU.pptx
Screening for colorectal cancer AAU.pptx
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-JANGAMA VISHA .pptx-
JANGAMA VISHA .pptx-
 
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of:  N...
HERBS AS HEALTH FOOD - Brief introduction and therapeutic applications of: N...
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 

How Should We Target Prevention Interventions?

  • 1. The UC San Diego AntiViral Research Center sponsors weekly presentations by infectious disease clinicians, physicians and researchers. The goal of these presentations is to provide the most current research, clinical practices and trends in HIV, HBV, HCV, TB and other infectious diseases of global significance. The slides from the AIDS Clinical Rounds presentation that you are about to view are intended for the educational purposes of our audience. They may not be used for other purposes without the presenter’s express permission. AIDS CLINICAL ROUNDS
  • 2. Network Informed Prevention Study? Davey Smith, MD Associate Professor of Medicine UCSD
  • 3. Who knows who these guys?
  • 5. Cholera Outbreak: space and time http://en.wikipedia.org/wiki/John_Snow_%28physician%29
  • 6. Snow Veterinary Research 2011 42:56 doi:10.1186/1297-9716-42-56
  • 7. How to define a network  Contact versus Transmission ◦ Behavior ◦ Social ◦ Venue  Molecular (genetic relatedness) ◦ Origins ◦ Timing ◦ Transmission linkages ◦ Transmission networks Retroviruses. Cold Spring Harbor Laboratory Press; c1997. Van Heuverswyn F. et al Nature. 2006 Nov 9;444(7116):164. Kober et al. Science 2000.
  • 8. Why Father’s Day is Important
  • 9. Do Genetic Backgrounds Matter? (Or how to blame everything on your parents) Smithsonian Natural History Museum 2011 www.hiv.lanl.gov/content/sequence/HIV/RE VIEWS/nomenclature/Nomen.html
  • 10. Kosakovsky Pond and Smith Clin Infect Dis. 2009 May 1;48(9):1306-9. Viral Background Host Background (e.g. HLA) CTL How can background genetics influence HIV disease?
  • 11. Defining Transmission Network and Clusters in San Diego  Even in this geographically localized and aggressively sampled cohort, genetic distances <1.5% were very rare (0.25 %). Pairwise Nucleotide Distance Count 0.00 0.05 0.10 0.15 0100030005000 Distances <1.5% 0.000 0.005 0.010 0.015 020406080 Potential transmission Network N=921 unique seqs Non-subtype B
  • 12. Switching Gears Networks are everywhere How many can you name is10 seconds?
  • 14. SO CAN MOLECULAR EPIDEMIOLOGYTELL US ANYTHING ABOUT NETWORKS?
  • 15. HIV is transmitted along a complex contact network Concept Contact Network Transmission network Node Individual HIV+ individual Edge A contact that could lead to HIV transmission, e.g. sexual, shared needle Transmission event Degree = edges connected to a node Number of contacts associated with a node Number of transmissions associated with a node HIV+ HIV- Contact w/o tranmission Transmission Degree = 7 Degree = 1 Degree = 3 Transmission network is a subset of the contact network
  • 16. HIV Molecular Epidemiology Has Been Used Before  Montreal and London: Primary infection drives local epidemics. (Brenner JID 2007, Fraser PLoS Med 2008, Leigh Brown JID 2011)  San Diego: Partner tracing identifies hubs. (Smith AIDS 2009)  Tijuana/San Diego: border offers some barrier (Mehta ARHR 2010)  Europe: some countries serve as hubs (Retrovirology 2009)
  • 17.  United States: Clustering associated with ◦ Not using ARVs ◦ CD4 >350 cells/ml ◦ Viral load 10,000-100,000 copies/ml ◦ Women cluster with other women ◦ African Americans clustered with other African Americans (Aldous CID 2012)
  • 18. Mol Epi-Network techniques are powerful  Can readily infer patterns of world-wide HIV-1 transmission  Found 4342 clusters using ~85,000 sequences from 141 countries.  A large IDU and MSM cluster spanned 18 countries (primarily from the former USSR). Wertheim JID 2013
  • 19. Defining Transmission Network and Clusters in San Diego  Even in this geographically localized and aggressively sampled cohort, genetic distances <1.5% were very rare (0.25 %). Pairwise Nucleotide Distance Count 0.00 0.05 0.10 0.15 0100030005000 Distances <1.5% 0.000 0.005 0.010 0.015 020406080 Potential transmission Network N=921 unique seqs Non-subtype B
  • 20. What kind of HIV network is San Diego? A random intervention would not work in a scale free network, but a targeted intervention would! Scale-free network Same size but one has Hubs Random network
  • 21. San Diego Network is Scale Free and Deeply Sampled Count 50100150 2000 2002 2004 2006 2008 2010 2050100200500 Year Nodes Edges
  • 22. So, can we use molecular epi and networks to do anything meaningful?  Hypothesis:We can reduce R0<1 in the San Diego HIV epidemic by identifying and intervening on the “hubs” of the network.
  • 23. Properties of SDPIC network  54% of individuals connected to someone else  A small proportion of individuals have many connections (high degree)  HIV transmission networks largely follow the model of preferential attachment – high degree nodes attract more new connections.  Perhaps the network degree of the individual can be informative for intervention?
  • 24. It pays to target highly connected nodes Degree = 7 Degree = 1 Targeting a low degree node has a local effect Targeting a high degree node has a global effect
  • 25. Transmission Network Score  DefineTNS as extent of the observed out-degree of the node and probability estimated from network degree distribution for the year of sampling.  A highly connected node has a high likelihood to have future connections-TNS Cluster
  • 26. Transmission Network Score  For each participant, we determined the degree (i.e. ‘connectivity’) of their node within the network on the date that corresponded to the first HIV pol sequence.  This was then used to predict how many new edges (i.e. contacts) the participant would acquire within the first year following their baseline sequence.
  • 27. Early versus delayed treatment
  • 28. LET USVISUALIZETHE PROBLEM Brought to you by Nadir Weibel and Sanjay Mehta
  • 29. Applications  Help us to understand the origins and dispersal of viral epidemics  Reconstructing the history of epidemics Understanding the detailed epidemiology of an epidemic in real time may help us design, prioritize and direct prevention efforts
  • 30. Obtaining a granular understanding of how the HIV epidemic occurred in a particular region will help us with future predictions on the how the epidemic will progress Example We find that HIV transmissions are occurring at a slow steady rate in IVDU, but occurring in bursts of related infections in MSM How? Suggests that we use this information to focus resources on contact tracing of acutely infected MSM
  • 31. Obtaining a real-time picture of the HIV epidemic in a region complete with socio-demographic correlates of risk will help us choose and target our interventions Example  Several new HIV infections are identified among heterosexual migrant farm-workers that are not IVDU  Infections are linked together, and to several infections identified in another migrant farm-worker camp How? Suggests that we target our interventions toward sex workers servicing these camps
  • 32.  Clever Information Visualization helps in making hidden connections apparent New Methods? Finding the cause of a cholera outbreak John Snow’s map of London of 1854 allowed to trace back an unexplainable outbreak to a malfunctioning water pump on Broad Street … just by superimposing cholera cases (in red) on the street map.
  • 33. Visualizing HIV Tracking: Challenges (1)  (Too?) many variables ◦ Demographic information (e.g. age, gender, race, ethnicity, marital status, sexual orientation, education level, birth country and city) ◦ Clinical data (e.g. HIV stage at diagnosis, current CD4 levels, HAART use) ◦ HIV sequence and phylogenetic clustering ◦ Sexually transmitted infections and sexual risk (e.g. transaction sex, commercial sex, number of partners) ◦ Illicit drug use (e.g. needle sharing, use of heroin, meth, alcohol) ◦ Risk venues (e.g. bathhouses, adult bookstores, bars, internet sites used to meet partners for sex or drug use) ◦ Geography (e.g. residence, border crossing).
  • 34. Visualizing HIV Tracking: Challenges (2)  Continuous data over time ◦ How do we visualize trends? ◦ How can we identify significant snapshots?  Unknown relationships between variables ◦ How do variable influence each other? ◦ Different views on data highlight different relationships  Different kind of networks ◦ Phylogenetic ◦ Geographic ◦ Social
  • 35. Approach  Stanford’s Data-Driven Documents (D3) D3: Data-Driven Documents Michael Bostock, Vadim Ogievetsky, Jeffrey Heer IEEE Trans. Visualization & Comp. Graphics (Proc. InfoVis), 2011 http://d3js.org/ http://vis.stanford.edu/papers/d3
  • 36. D3 Example / Inspiration
  • 37. Preliminary work (1)  HIV Datasets ◦ >1000 data entries collected ◦ 3 different sites:  Primary Infection Cohort  UCSD Owen Clinic  San Diego County Epidemiology Department  Phylogenetic cluster analysis ◦ Distance between single sequences ◦ 111 clusters found
  • 38. Preliminary Work (2)  Visualization ◦ Clusters grouped in circles ◦ Descriptive statistics for the cluster  Number of subjects per cluster (size of the circle)  average age (color of the circle)  male/female percentage  Ethnicity  Sexual Orientation
  • 39. Demo
  • 40. Next Steps  Multi-layered descriptions of phylogenetic clusters  Network connectivity within the cluster and across clusters  Time-based dynamic update of clusters  Identification of specific important changes
  • 41. In a (not too) far future?  Dynamic Real-time Geographic visualizations  Automatic detection of anomalies ◦ Machine learning algorithms  Ultra-ScaleVisualizations ◦ Calit2 Wall Displays (VROOM)
  • 42. Public Health Approach • Prevention measures cannot be a one-size fits all. • Use network analytical methods to characterize HIV transmission dynamics within a population • Use network and phylogenetic methods to identify cores, bridges and hubs • Focus outreach and prevention programs on identified cores, bridges and hubs • Since network dynamics can change (venues, susceptible populations, STIs, drug use, etc.) network surveillance should also be dynamic. • Epidemiologic surveillance • HIV genetic surveillance (genotypes) 41
  • 43. Legal:Take the ‘C’ out of CSI  The identification of individuals who have transmitted HIV can have significant legal implications.  Therefore for these data to be used for public health purposes there must be: ◦ Decriminalization of unintended HIV transmission during consensual exposure. ◦ Legal recognition that phylogenetic linkage using pol sequences does not prove beyond a reasonable doubt that transmission between partners occurred, such as with a third party intermediary ◦ The legal precedent for admitting phylogenetic evidence has set the bar extremely high [Scaduto PNAS, 2010], and requires very complex analyses of multiple source and recipient sequence isolates. 42
  • 44. Analyze HIV pol sequences in real time in the background of all sequences Generate TNS TNS high Generate Risk Profile and Intervention Plan DatAvailable for Risk Profile • Demographics • Risk behavior (MSM, IDU) • Venues (bars, bathhouses, shooting galleries, internet sites) • Estimated duration of infection (acute, early, chronic) • Clinical (CD4 and viral load) • No personally identifying information Ring Intervention Target identified venues HIV Testing, Counseling, STI testing, Needle Exchange, etc. Intervention Team • Nurse • Social worker • Test Counselor Intervention success can be measured by observing phylogenetic lineages dying out (Wertheim et al. 2011) TNS low= follow
  • 46. Coverage- Acknowledgements Sanjay Mehta Nadir Weibel Sergei Kosakovsky Pond Susan Little Kimberly Bouwer Richard Garfein Igor Grant Tom Patterson Doug Richman Stephanie Strathdee Jason Young Joel Wertheim